Skip to main content
TipRanks
Go Ultimate75% OFF

StemCell Institute (7096) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

StemCell Institute has a market cap or net worth of JPY 6.56B. The enterprise value is JPY 5.75B.

Market Cap
JPY 6.56B
Enterprise Value
JPY 5.75B

Share Statistics

StemCell Institute has 10,246,600 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
10,246,600
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

StemCell Institute’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 3.33%.

Return on Equity (ROE)
0.06
Return on Assets (ROA)
0.02
Return on Invested Capital (ROIC)
3.33%
Return on Capital Employed (ROCE)
0.06
Revenue Per Employee
24.03M
Profits Per Employee
1.33M
Employee Count
117
Asset Turnover
0.35
Inventory Turnover
20.35

Valuation Ratios

The current PE Ratio of StemCell Institute is 57.55. StemCell Institute’s PEG ratio is -1.34.

PE Ratio
57.55
PS Ratio
2.31
PB Ratio
2.36
Price to FCF
0.00
Price to Operating Cash Flow
0.00
PEG Ratio
-1.34

Income Statement

In the last 12 months, StemCell Institute had revenue of 2.81B and earned 155.92M in profits. Earnings per share was 15.44.

Revenue
2.81B
Gross Profit
1.71B
Operating Income
202.66M
Pretax Income
217.79M
Net Income
155.92M
EBITDA
379.99M
Earnings Per Share (EPS)
15.44

Cash Flow

In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.

Operating Cash Flow
0
Free Cash Flow
0
Free Cash Flow per Share
0.00

Dividends & Yields

StemCell Institute pays an annual dividend of JPY 25.00, resulting in a dividend yield of ―

Dividend Per Share
JPY 25.00
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
0.00%
Earnings Yield
1.74%

Stock Price Statistics

Beta
0.53
52-Week Price Change
-20.00%
50-Day Moving Average
720.80
200-Day Moving Average
747.02
Relative Strength Index (RSI)
32.42
Average Volume (3m)
5,223

Important Dates

StemCell Institute upcoming earnings date is Feb 09, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 10, 2026
Next Earnings Date
Feb 09, 2027
Ex-Dividend Date
Sep 27, 2024

Financial Position

StemCell Institute as a current ratio of 1.17, with Debt / Equity ratio of 17.67%

Current Ratio
1.17
Quick Ratio
1.16
Debt to Market Cap
0.06
Net Debt to EBITDA
-6.21
Interest Coverage Ratio
37.20

Taxes

In the past 12 months, StemCell Institute has paid 86.78M in taxes.

Income Tax
86.78M
Effective Tax Rate
0.40

Enterprise Valuation

StemCell Institute EV to EBITDA ratio is 15.49, with an EV/FCF ratio of 0.00.

EV to Sales
1.58
EV to EBITDA
15.49
EV to Free Cash Flow
0.00
EV to Operating Cash Flow
0.00

Balance Sheet

StemCell Institute has JPY 2.83B in cash and marketable securities with JPY 473.81M in debt, giving a net cash position of JPY 2.36B billion.

Cash & Marketable Securities
JPY 2.83B
Total Debt
JPY 473.81M
Net Cash
JPY 2.36B
Net Cash Per Share
JPY 230.35
Tangible Book Value Per Share
JPY 286.20

Margins

Gross margin is 59.21%, with operating margin of 3.66%, and net profit margin of 4.01%.

Gross Margin
59.21%
Operating Margin
3.66%
Pretax Margin
4.27%
Net Profit Margin
4.01%
EBITDA Margin
10.18%
EBIT Margin
3.66%

Analyst Forecast

The average price target for StemCell Institute is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
2.55%
EPS Growth Forecast
-43.06%

Scores

Smart Score
―
AI Score
56